CANDRIAM BELGIUM S.A.


OWNERSHIP STRUCTURE AND HISTORY
Candriam Belgium, société anonyme (“Candriam”) was created in 1998 and became a registered investment adviser with the Securities and Exchange Commission (“SEC”) on December 2, 2014. Candriam is a wholly‐owned subsidiary of Candriam Luxembourg, société en commandite par actions (“Candriam Luxembourg”). The group Candriam (“CANDRIAM”) is a leading pan‐European multi‐specialist asset manager with a 20‐year track record and a team of approximately 540 experienced professionals. CANDRIAM has established investment management centers in Brussels, Paris, Luxembourg and London and has experienced sales forces covering Europe, the Middle East and the US. CANDRIAM is owned by Candriam Group (formerly “New York Life Investment Management Global Holdings S.à r.l.”), which is a wholly‐owned subsidiary of New York Life Insurance Company (“New York Life”). Founded in 1845 and headquartered in New York, New York Life is a mutual life insurance company that is one of the largest life insurers in the world. While Candriam maintains autonomous investment processes, it may leverage the resources and services of its affiliates, Candriam Luxembourg, Candriam France, and New York Life Investment Management LLC (“New York Life Investments”) for certain functions. In addition, certain officers of New York Life Investments may also serve as officers of Candriam. New York Life Investments, which is also a wholly‐owned subsidiary of NYLIM Holdings, is a related investment adviser registered with the SEC.
CANDRIAM’S ADVISORY SERVICES
Candriam provides asset management services to clients globally. This brochure has been prepared to provide information to Candriam’s US clients, which currently include at least two registered investment companies and accounts of US natural persons. Where relevant to a US client, however, this brochure provides additional information about Candriam’s non‐US advisory business. Candriam provides discretionary and non‐ discretionary investment advisory services to its clients. Candriam has $95.74 billion of assets under supervision.1 Candriam offers a variety of investment strategies that clients can select depending on their investment objectives. Clients can impose reasonable restrictions or limitations on how Candriam manages their accounts. These restrictions or limitations generally appear either in the client’s investment management agreement or in other investment guidelines, including a prospectus or other offering document. Additional information about this process can be found under Item 16. General information about investment strategies offered by Candriam can be found under Item 8. Candriam does not currently participate in wrap fee programs. please register to get more info

Open Brochure from SEC website
Assets
Pooled Investment Vehicles $61,328,739,859
Discretionary $102,794,503,897
Non-Discretionary $1,376,395,851
Registered Web Sites

Related news

Aileron Therapeutics Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Akers Biosciences Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Morgan Stanley IM: ESG in Sovereign Fixed Income Investing - Identifying Opportunities, Correcting Biases

In 2019, we published our Morgan Stanley Investment Management (MSIM) Fixed Income “ESG and Sovereign Fixed Income Investing: A Better Way” approach. We highlighted our thesis that countries ...

Morgan Stanley: ESG in Sovereign Fixed Income Investing - Identifying Opportunities, Correcting Biases

In 2019, we published our Morgan Stanley Investment Management (MSIM) Fixed Income “ESG and Sovereign Fixed Income Investing: A Better Way” approach. We highlighted our thesis that countries ...

Candriam Clickinvest B - Index Linked 14

Candriam Clickinvest B - Index Linked 14 is an open-end fund registered in Belgium. The objective of the Fund is to return 90% of the capital invested at maturity (02/03/2015) and a return based ...

Akers Biosciences Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Janus Henderson Investors: Abenomics - more arrows in the quiver?

On 28 August 2020, Japanese Prime Minister Shinzo Abe announced his resignation due to health reasons. The move also signified an end to almost eight years of ‘Abenomics’, economic policies ...

Janus Henderson Investors: Abenomics - more arrows in the quiver?

Abenomics has benefited Japanese stocks, created jobs and resulted in a more stable economy. Should Suga become Abe’s successor, Abenomics is likely to continue, and could even be enhanced. In ...

Aileron Therapeutics Inc.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Janus Henderson Investors: COVID and tech: what have we learned as investors?

In this video, Denny Fish, portfolio manager for the Global Technology & Innovation Strategy, shares his thoughts on how COVID has impacted technology and the key considerations as an investor in ...
Loading...
No recent news were found.